ARCHIVES

In Brief: FDA To Review Preclinical Testing, Phase I Protocols At Open Advisory Group Meeting

This article is from The Cancer Letter archive.

Vol. 01 No. 46 | November 14, 1975

Download PDF Visit The Full Archive

Related Articles

Zerhouni Appoints Kington As Deputy Director

February 14, 2003

Rosenberg’s Latest Results: 22% Response Seen With LAK/IL-2, 13% With High Dose IL-2 Alone

April 10, 1987

Academic Oncologists Losing Control Over Phase I Trials As For-Profits Expand

March 26, 2010

Dana-Farber Picks Rosenthal To Direct New Center For Integrated Therapies.

June 23, 2000

Gramm-Rudman Cut Facing NCI Could Take $85 Million

October 20, 1989

Collins, Lander, Botstein Win Albany Prize.

March 12, 2010